Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Chelyabinsk Press-Forging Plant recommended dividends

4/10/24 CHKZ

Novabev extended partnership with Ararat

4/10/24 BELU

O'Key sold plots of land for hypermarkets

4/10/24 OKEY

Henderson's sales in March were up 36%

4/10/24 HNFG

Board of Directors of Positive Technologies recommended dividends

4/9/24 POSI

Positive Technologies reported for 2023 by IFRS

4/9/24 POSI

OGK-2 increased electricity generation by 19.1% in Q1

4/9/24 OGKB

Ozon expects to start redomiciling in 2024

4/9/24 OZON

Raspadskaya reported for 3 months of 2024 by RAS

4/9/24 RASP

Novabev reported a decline in performance

4/9/24 BELU